Novel Applications of Artificial Intelligence in Personalized Medicine

A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Methodology, Drug and Device Discovery".

Deadline for manuscript submissions: 15 October 2025 | Viewed by 108

Special Issue Editor


E-Mail Website
Guest Editor
Intensive Care Unit, Sismanogleio General Hospital, 37 Sismanogleiou Str., 15126 Marousi, Greece
Interests: antibiotic resistance; antimicrobial resistance; intensive care unit; ICU; machine learning; predictive modeling; artificial intelligence; MI techniques; biostatistics and clinical bioinformatics.

Special Issue Information

Dear Colleagues,

We are pleased to invite you to contribute to this Special Issue on "Novel Applications of Artificial Intelligence in Personalized Medicine", which will be published in the Journal of Personalized Medicine. The intersection of artificial intelligence (AI) and personalized medicine has become a crucial area of research, offering transformative possibilities for individualized patient care. By leveraging AI's capabilities in data analysis, pattern recognition, and predictive modeling, healthcare is moving toward more precise, efficient, and patient-specific solutions.

This Special Issue aims to explore cutting-edge advancements in the application of AI to personalized medicine, aligning closely with the journal's mission to highlight innovative interdisciplinary research. The focus will be on groundbreaking approaches that integrate AI with healthcare to address critical challenges, from improving diagnostic accuracy to optimizing therapeutic strategies. This issue will provide a platform for researchers and practitioners to share insights and contribute to this rapidly evolving field.

In this Special Issue, original research articles and reviews are welcome.
Research areas may include (but are not limited to) the following:

  • AI-driven predictive modeling for personalized treatment;
  • Applications of AI in genomics and proteomics;
  • Development of AI tools for patient-specific drug discovery;
  • Ethical and practical challenges in AI-based healthcare;
  • AI in real-world clinical applications for personalized care.

We look forward to receiving your valuable contributions to this exciting Special Issue.

Dr. Aikaterini Sakagianni
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • artificial intelligence 
  • personalized medicine 
  • predictive modeling 
  • genomics 
  • proteomics 
  • AI-driven diagnostics 
  • patient-specific treatment 
  • drug discovery 
  • healthcare innovation 
  • clinical applications of AI

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

15 pages, 557 KiB  
Article
Semi-Supervised Learning for Predicting Multiple Sclerosis
by Sotiris Kotsiantis, Georgia Melagraki, Vassilios Verykios, Aikaterini Sakagianni and John Matsoukas
J. Pers. Med. 2025, 15(5), 167; https://doi.org/10.3390/jpm15050167 - 24 Apr 2025
Viewed by 110
Abstract
Background: Multiple Sclerosis (MS) is a chronic autoimmune disease of the central nervous system with a propensity to inflict severe neurological disability. Accurate and early prediction of MS progression is extremely crucial for its management and treatment. Methods: In this paper, [...] Read more.
Background: Multiple Sclerosis (MS) is a chronic autoimmune disease of the central nervous system with a propensity to inflict severe neurological disability. Accurate and early prediction of MS progression is extremely crucial for its management and treatment. Methods: In this paper, we compare a number of self-labeled semi-supervised learning methods used to predict MS from labeled and unlabeled medical data. Specifically, we compare the performance of Self-Training, SETRED, Co-Training, Co-Training by Committee, Democratic Co-Learning, RASCO, RelRASCO, CoForest, and TriTraining in different labeled ratios. The data contain clinical, imaging, and demographic features, allowing for a detailed comparison of each method’s predictive ability. Results and Conclusions: The experimental results demonstrate that several self-labeling semi-supervised learning (SSL) algorithms perform competitively in the task of Multiple Sclerosis (MS) prediction, even when trained on as little as 30–40% of the labeled data. Notably, Co-Training by Committee, CoForest, and TriTraining consistently deliver high performance across all metrics (accuracy, F1-score, and MCC). Full article
Show Figures

Graphical abstract

Back to TopTop